The aim of the present study was to estimate the relative risk of non-puerperal lactation in patients using antidepressants in general, and specifically for serotonergic (selective serotonin reuptake inhibitors (SSRIs) and clomipramine) and nonserotonergic antidepressants. Methods All suspected adverse drug reactions in women and reported from January 1986 until August 1996 to the Netherlands Pharmacovigilance Foundation, a spontaneous adverse drug reaction reporting programme, were analysed. Adverse drug reaction (ADR) reporting odds ratios, defined as the ratio of the exposure odds among reported cases of non-puerperal lactation to the exposure odds of reported other ADRs, were calculated adjusted for age and year of reporting. Results Thirty-eight cases of non-puerperal lactation were reported, of which 15 were associated with the use of antidepressant drugs. In general, antidepressants were associated with a higher risk of non-puerperal lactation in comparison with other drugs (ADR reporting odds ratio 8.3 [95%CI: 4.3-16.1]). Serotonergic antidepressants (selective serotonin reuptake inhibitors (SSRIs) and clomipramine) were associated with a higher risk ), whereas other antidepressants were not (OR 1.6 [95%CI: 0.2-11.6]), compared with all other drugs. Conclusions Our results indicate that serotonergic antidepressants are associated with an approximately eight times higher risk of non-puerperal lactation compared with other antidepressants. This effect is probably mediated by an indirect inhibition effect of serotonin on the dopaminergic transmission. This finding is in line with the occurrence of other antidopaminergic effects, such as extrapyramidal symptoms, in patients using serotonergic antidepressants.
Introduction Methods
Non-puerperal lactation or galactorrhoea occurs relatively Source frequently as an adverse drug reaction (ADR) in patients treated with antipsychotic agents and other medicines acting
The Netherlands Pharmacovigilance Foundation is a network of eight regional centres for spontaneous adverse drug as dopamine antagonists [1] . This effect has rarely been associated with the use of antidepressant drugs. Although reaction reporting by health care professionals which has operated since 1986 and performs its tasks for the Dutch several case reports of non-puerperal lactation associated with the use of antidepressant drugs have appeared in the Medicines Evaluation Board since 1996. Health care professionals report suspected adverse drug reactions on a medical scientific literature since 1964, it is still unknown whether the risk is the same for patients using different standard form. Data on this report form include gender and date of birth of the patient involved, information about antidepressants.
The aim of this study was to evaluate the cases of non-the suspected medicine (name, dose, frequency, route of administration), information about the event (description of puerperal lactation associated with antidepressant drugs reported to a spontaneous adverse drug reaction programme the event, onset of symptoms), concomitantly used medication, and other available information considered relevant in the Netherlands and to assess whether these data show a difference in risk between classes of antidepressants.
by the reporter (including diseases and factors possibly related to the event, laboratory findings). The identity of the patient is only known to the reporting health care professional in accordance with current privacy legislation. All reported suspected adverse drug reactions are evaluated includes an assessment of each individual case, provision of feedback to the reporting health care professional, and 'serotonergic' antidepressants vs non-antidepressants, and the other providing an estimate of the risk of the other classification according to the adverse reaction terminology of the World Health Organisation (WHO-ART) [2] .
antidepressants relative to non-antidepressants. The ADR reporting odds ratios were calculated as: (a/c)/(b/d) (see Figure 1 ) and expressed as point estimates Validation of the cases with 95% confidence intervals (95%CI). In addition, ADR reporting odds ratios adjusted for age and year of reporting All cases of non-puerperal lactation (i.e. discharge of milk or milk-like secretions from the breast in the absence of were calculated using logistic regression analysis. Student's t-test was used to compare the mean ages of the cases and pregnancy or beyond 6 months post-partum) reported in association with antidepressant drugs from January 1986 the controls. All statistical analyses were performed using EGRET. until August 1996 were analysed in detail. The health care professionals who reported these cases were approached, if necessary, for additional information using a mailed question-Results naire. The main purpose of this questionnaire was to verify whether it probably was an adverse drug reaction (i.e.
In total 14 439 suspected adverse drug reactions, restricted to women, were reported to the Netherlands caused by the antidepressant drug) or whether it occurred during treatment with the antidepressant but was not likely Pharmacovigilance Foundation during the study period. There were 38 (3 per 1,000) reports of non-puerperal to be caused by it. The following questions were asked: 1) What was the course and outcome of the lactation? 2) Have lactation. Fifteen cases (14 per 1,000) out of a total of 1,097 reported ADRs to antidepressant drugs were attributed to prolactin levels been determined and, if so, what were they? 3) Was any other illness present which could have caused the use of an antidepressant drug by the reporting health care professionals. Characteristics of these fifteen patients are the lactation disorder, such as prolactinoma, hypothyroidism, liver cirrhosis or severe renal disease? 4) Was the woman summarised in Table 1 . Prolactin was measured in five patients and was within the normal range in four of these. ever pregnant and, if so, when was the last pregnancy? In addition, information about concomitantly used medication
The disorder resolved in all patients either after continuation, cessation or dose reduction of the drug. Other medicines (including oral contraceptives) was obtained from pharmacy dispensing records. associated with non-puerperal lactation were antidopaminergic antiemetics (5 cases), antipsychotic drugs (4), histamine H 2 -receptor blockers (2), oral contraceptives (3), Analysis progestagens (3), fenfluramine, captopril, co-trimoxazole, valproic acid, astemizole and acetazolamide (1 each). All reported suspected ADRs classified as the WHO-ART included terms 'non-puerperal lactation', 'galactorrhoea' or
The reports of non-puerperal lactation (whether or not associated with an antidepressant) concerned women who 'hyperprolactinaemia' were defined as the cases. All reported suspected ADRs classified other than the included terms were significantly younger than the women involved in other reports (mean (s.d.) age: 33 (10.6) vs 51 (18.9) years; mentioned above were defined as the controls. The analyses were restricted to women, because predominantly women P<0.001). There was a clear association between the use of an antidepressant drug and the reporting of non-puerperal are at risk for developing non-puerpural lactation. An ADRreporting odds ratio was calculated based upon the concepts lactation (Table 2) . Because the ADR reporting odds ratios were hardly affected by differences in age and year of of Finney [3] , and as has been applied by Stricker et al. [4] . It is defined as the ratio of the exposure odds among reporting, only the adjusted ratios are shown. The ADR reporting odds ratio for the risk of non-puerperal lactation reported cases of a certain suspected ADR to the exposure odds among reported non-cases (controls). The ADR reporting odds ratio provides an estimate for the risk of developing a certain event (i.e. non-puerperal lactation) for patients using the index drug relative to patients using reference drug(s). The index group consisted of antidepressants and the reference consisted of all medicines other than antidepressants.
For calculating the ADR reporting odds ratio two approaches were used. In the first approach, the ADR reporting odds ratio estimated the risk of non-puerperal lactation for all antidepressants relative to all medicines other than antidepressants. In the second approach, two categories of antidepressants were considered: those antidepressants that are rather selectively blocking the reuptake of serotonin in comparison with noradrenaline (i.e. the selective serotonin reuptake inhibitors (SSRIs) and clomipramine) [5] , and antidepressants which do not have this selectivity (i.e. all other antidepressants). The second approach resulted in two the risk of non-puerperal lactation for women using associated with any antidepressant use vs non-antidepressant ant drug appeared in the medical scientific literature a few years after the introduction of imipramine [6] . Several case use was 8.3 (95%CI: 4.3-16.1). The serotonergic antidepressants were associated with a higher risk (odds ratio:
reports suggesting a (causal) relationship between the use of antidepressant drugs and the occurrence of non-puerperal 12.7 [95%CI: 6.4-25.4]) than were the other antidepressants (odds ratio: 1.6 [95%CI: 0.2-11.6]) in comparison with lactation have been published since. These reports concerned a variety of antidepressant drugs, including amitriptyline [7] , non-antidepressants. From these results, we may conclude that the risk in women using serotonergic antidepressants is amoxapine [8, 9] , clomipramine [10, 11] , maprotiline [12] , dothiepin [13], fluvoxamine [14, 15] , fluoxetine [16, 17] eight times (odds ratio: 8.2 [95%CI: 1.1-64]) higher than in women using non-serotonergic antidepressants. and sertraline [18, 19] . According to our data we can add paroxetine to this list. Although medicines are a common cause of non-puerperal Discussion lactation, this disorder can also have other etiologic origins or occur without an obvious pathologic reason [20] . Non-The first case report concerning the occurrence of nonpuerperal lactation associated with the use of an antidepress-puerperal lactation can occur in patients with, for example, hypothyroidism, prolactinoma, liver cirrhosis, or renal new drugs, in contrast to many other countries. We feel, therefore that the ADR-reporting odds ratio provides a valid failure. Our patients with antidepressant associated galactorrhoea, did not have illnesses which may have led to estimate of the actual relative risk of serotonergic vs non-serotonergic antidepressants for causing non-puerperal lactation, nor had they recently been pregnant. Several women, however, used other medicines which have been lactation. Unfortunately we were not able to study in detail whether the reporting rates for the newer antidepressants associated with the occurrence of non-puerperal lactation: four women used oral contraceptives, two used an anti-(predominantly serotonergic) were higher than for the older antidepressants ( predominantly non-serotonergic). psychotic drug and one women used an antidopaminergic propulsive drug. With regard to oral contraceptives the In general, the mechanism that most frequently leads to non-puerperal lactation is an increase in serum prolactin [1] . effect on lactation is complex. Lactation is more likely to occur after cessation of the oral contraceptive than during
The secretion of prolactin primarily is under the inhibitory control of hypothalamic dopamine which binds to dopa-its use [21] . Oestrogens may, however, also enhance the sensitivity of the breast to other lactation inducing factors.
minergic-2-receptors on lactotrophic cells. Antidepressant drugs are not directly acting dopamine antagonists [5] . The use of oral contraceptives may therefore have predisposed these women to the development of lactation after Several pharmacological studies showed that prolactin secretion is also mediated by serotonin. The serotonergic the start of the antidepressant [22] . The same may be true for the women using an antipsychotic or domperidone:
anorectic agent, fenfluramine, for example, is known to increase serum prolactin level [25] . Serotonin mediated although they did not experience non-puerperal lactation without the antidepressant, the addition of the antidepressant prolactin release may be a result of either direct stimulation of postsynaptic serotonin receptors in the hypothalamus or may have triggered off the lactation. Although causality is difficult to establish from case reports, our findings provide presynaptic serotonin receptor mediated inhibition of dopamine release. The latter seems the most likely mechanism. further evidence that antidepressant drugs may occasionally induce non-puerperal lactation in susceptible patients.
It also explains the occurrence of extrapyramidal symptoms induced by selective serotonin reuptake inhibitors [26] . This Besides the individual case reports, also the ADR reporting odds ratios suggest a causal relationship between antidepress-means that serotonergic agents can actually cause effects related to dopaminergic inhibition: not via direct effects on ant drug use and the occurrence of non-puerperal lactation. We observed a disproportionate share of antidepressant drugs the secretion or reuptake of dopamine or on the dopamine receptor, but indirectly via serotonin [27] . in the total number of case reports of non-puerperal lactation, as is reflected in the ADR reporting odds ratio
The role of prolactin in non-puerperal lactation is not clear. The results of animal and human studies investigating of antidepressants as a group versus other medicines. Furthermore, our data indicate that this side-effect occurs the effects of individual antidepressants on plasma concentrations of prolactin are controversial: they showed either approximately eight times as often with antidepressants relatively selectively blocking the reuptake of serotonin in normal or elevated levels. Studies with antipsychotics have shown that there is no simple relationship between galac-comparison with other antidepressants.
One can argue whether estimates for the relative risk of torrhoea and the prolactin increment induced by these drugs [28] . In our study, prolactin levels were measured in five actually developing an ADR derived from spontaneously reported suspected ADRs are valid, because only a fraction patients; in four of them these were within the range considered normal. of all ADRs is actually reported. Non-differential underreporting is not relevant with respect to validity but only
In conclusion, our data provided additional evidence for the existence of a causal relationship between the use of with respect to precision [23] . Selective underreporting on the other hand is a serious threat to validity. It has, for antidepressant drugs and the occurrence of non-puerperal lactation as an adverse event. Furthermore, they indicate example, been shown that side-effects which are known to the physician are less frequently reported than unknown or that the risk is substantially higher in patients using serotonergic antidepressants in comparison with patients serious side effects [24] . This phenomenon may explain the small number of reported cases of non-puerperal lactation using non-serotonergic antidepressants. Although nonpuerperal lactation usually is not harmful, patients may feel associated with the use of drugs which are known to cause this ADR rather frequently such as antipsychotic drugs and embarrassed about it. Furthermore, awareness of this ADR may prevent unnecessary diagnostic and therapeutic other antidopaminergic drugs. This effect may have led to an overestimation of the risk of all antidepressants when procedures. compared with other medicines. With respect to the difference between serotonergic and non-serotonergic anti-We thank the physicians and pharmacists who reported depressants, we think, however, that it is unlikely that these cases and were willing to provide additional selective underreporting greatly overestimated or diluted the information. relative risk. Although the occurrence of non-puerperal lactation as a side-effect of treatment with an antidepressant has been reported in the literature, prescribers in general References were not aware of this ADR and it is not mentioned in the official labelling of most of these medicines, nor was this
